Parallel Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 302 shares of AMPH stock, worth $7,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
302
Previous 58
420.69%
Holding current value
$7,012
Previous $1,000
500.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.1MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$62.4 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$47.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$37.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$36.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.14B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...